Company news

Zelira Therapeutics Ltd. news in 2024

Zelira Therapeutics Ltd.'s news releases, calls and decks from 2024, newest first.

View company

September 2024 Quarterly Activities Report

October 29, 2024

Appendix 4C Cash Flow Report

October 29, 2024

Appendix 4E and Financial Report to Shareholders

August 28, 2024

June 2024 Quarterly Activities Report

July 29, 2024

ZLD Advances HOPE Autism Drug Program with U.S FDA Meeting

July 11, 2024

ZLD secures US$1.4M unsecured Chairman loan facility

June 30, 2024

HOPE SPV receives US$681,000 third tranche of funding

May 22, 2024

March 2024 Quarterly Activities Report

April 29, 2024

Zelira receives $919,000 R&D Tax Incentive Scheme Refund

April 15, 2024

Appendix 4D & FY24 Interim Financial Report

February 22, 2024

December 2023 Quarterly Activities Report

January 31, 2024

HOPE SPV receives US$819,000 second tranche of funding

January 7, 2024

Decks in 2024